Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Mismatch Repair01:36

Mismatch Repair

44.9K
Overview
44.9K
Mismatch Repair01:20

Mismatch Repair

7.0K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.0K
Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Nature·2009
Same author

Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients.

International journal of hematology·2008
Same author

Long-term sustained mixed chimerism after allogeneic stem cell transplantation in a patient with severe aplastic anemia.

Internal medicine (Tokyo, Japan)·2007
Same author

CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells.

Leukemia & lymphoma·2006
Same author

Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations.

Leukemia research·2006
Same author

A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2006

Related Experiment Video

Updated: Mar 25, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K

Molecular pathogenesis of MDS.

Hisamaru Hirai1

  • 1Graduate School of Medicine, University of Tokyo, Japan.

International Journal of Hematology
|November 15, 2002
PubMed
Summary

Myelodysplastic syndromes (MDS) are clonal stem cell disorders causing ineffective blood cell production and resistance to treatment. Genetic alterations in MDS disrupt cell growth and differentiation, contributing to leukemogenesis.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders.
  • MDS is characterized by ineffective hematopoiesis and high risk of transformation to acute myeloid leukemia.
  • Current therapies for MDS are often ineffective.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying MDS pathogenesis.
  • To identify genetic lesions and signal transduction pathway disruptions in MDS.
  • To explore the role of tumor suppressor genes in MDS development.

Main Methods:

  • Genomic analysis of chromosomal abnormalities in MDS.
  • Identification and analysis of genetic alterations in key signal transduction molecules.

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.5K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.2K

Related Experiment Videos

Last Updated: Mar 25, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

2.0K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.5K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

10.2K
  • Study of transcription factors regulating hematopoietic stem cell proliferation and differentiation.
  • Main Results:

    • MDS involves genetic lesions, including deletions and translocations of specific chromosomes (5, 7, 11, 12, 13, 20).
    • Disruptions in signal transduction pathways involving growth factor receptors, RAS molecules, cell cycle regulators, and transcription factors are observed.
    • Transcription factors regulating hematopoietic stem cell proliferation and differentiation are notably altered.

    Conclusions:

    • MDS pathogenesis involves the accumulation of genetic lesions and disruption of critical signaling pathways.
    • Unidentified tumor suppressor genes likely play a significant role in MDS.
    • Further molecular dissection of MDS is crucial for understanding multistep leukemogenesis and developing effective therapies.